CL2015001621A1 - Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos. - Google Patents

Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos.

Info

Publication number
CL2015001621A1
CL2015001621A1 CL2015001621A CL2015001621A CL2015001621A1 CL 2015001621 A1 CL2015001621 A1 CL 2015001621A1 CL 2015001621 A CL2015001621 A CL 2015001621A CL 2015001621 A CL2015001621 A CL 2015001621A CL 2015001621 A1 CL2015001621 A1 CL 2015001621A1
Authority
CL
Chile
Prior art keywords
tablets
formation
granules
press
sodium ibuprofen
Prior art date
Application number
CL2015001621A
Other languages
English (en)
Inventor
Latria N Boudoin
Gregory H Lambeth
Eric W Limatta
Patrick C Hu
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015001621(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of CL2015001621A1 publication Critical patent/CL2015001621A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
CL2015001621A 2012-12-14 2015-06-11 Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos. CL2015001621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (1)

Publication Number Publication Date
CL2015001621A1 true CL2015001621A1 (es) 2015-08-07

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015001621A CL2015001621A1 (es) 2012-12-14 2015-06-11 Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos.

Country Status (9)

Country Link
EP (1) EP2931261A1 (es)
JP (1) JP6285952B2 (es)
CN (1) CN104884048B (es)
BR (1) BR112015013945A8 (es)
CA (1) CA2894272A1 (es)
CL (1) CL2015001621A1 (es)
HK (1) HK1210591A1 (es)
MX (1) MX2015007571A (es)
WO (1) WO2014093073A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043614A1 (en) 2017-08-31 2019-03-07 Novartis Ag PROCESS FOR THE PREPARATION OF GRANULES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20120076865A1 (en) * 2010-03-24 2012-03-29 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

Also Published As

Publication number Publication date
HK1210591A1 (en) 2016-04-29
MX2015007571A (es) 2016-04-15
EP2931261A1 (en) 2015-10-21
CN104884048A (zh) 2015-09-02
JP2016508124A (ja) 2016-03-17
BR112015013945A2 (pt) 2017-07-11
CA2894272A1 (en) 2014-06-19
CN104884048B (zh) 2018-11-23
BR112015013945A8 (pt) 2019-10-08
WO2014093073A1 (en) 2014-06-19
JP6285952B2 (ja) 2018-02-28

Similar Documents

Publication Publication Date Title
BRPI1016215A2 (pt) processo para á preparação de um comprimido de desintegração rápida, sistema para realizar um processo, e, embalagem.
CL2015000739A1 (es) Compuesto para juntas, ensamble de muro, y métodos y productos relacionados a estos.
BRPI0914918A2 (pt) forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
CO6821948A2 (es) Tableta a prueba de alteración que proporciona liberación inmediata del fármaco
CL2015000893A1 (es) Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
IT1400982B1 (it) Collirio osmotico trans-epiteliale per la cura del cheratocono.
CO6781544A2 (es) Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración.
BR112013007256A2 (pt) sistema de preparação de bebida a partir de um produto de difusão contido em uma cápsula intercambiável.
BR112014030067A2 (pt) processo para a fabricação de composição de vapor, e, composição de vapor.
CL2015000892A1 (es) Proceso para la co-producción de bioenergía y productos desde la conversión integrada de biomasas y residuos municipales.
HN2012002057S1 (es) Paquete blister en forma de concha no. 2
BRPI1016190A2 (pt) compostos farmacêuticos.
CL2014001960A1 (es) Metodo para producir una composición que contiene galacto-oligosacáridos.
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
NI201200151S (es) Paquete blister para productos
CL2015002283S1 (es) Envase para almacenar productos.
BR112013025715A2 (pt) métodos para a deformação mecânica de materiais.
CL2013000831A1 (es) Metodo para la determinacion del contenido de alergenos de una composicion.
CL2015000390A1 (es) Preparación farmacéutica sólida que contiene levotiroxina sodica, gelatina, acido citrico y un relleno; proceso para la produccion de la preparacion farmaceutica
CL2013000688A1 (es) Procedimiento para obtener una composicion de igg a partir de una composicion de igg parcialmente purificada.
CL2015000018A1 (es) Proceso para la producción de un gránulo detergente, gránulo detergente y composición detergente que comprende dicho gránulo
FR2944023B1 (fr) Procede de preparation de superplastifiants.
AP3309A (en) Ibuprofen chewable tablet
CL2015001621A1 (es) Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos.
FR2957060B1 (fr) Distributeur de comprimes.